Preferential Activity of Petiveria alliacea Extract on Primary Myeloid Leukemic Blast

Figure 5

Response to extracts and chemotherapeutics in patients with relapse acute leukemia. Heat map showing resistance or sensitivity to treatment with extracts and chemotherapeutics individually or in combination on cells of patients with relapse acute leukemia. Acute lymphoblastic leukemia relapsed patients: SC0013 R, SC0015 R, SC0018 R (chemotherapy: idarubicin). Acute myeloid leukemia relapsed patients: SC0019 R, SC0034 R, SC0039 R (chemotherapy: azacitidine for SC0019 R and SC0039 R patients, and arsenic trioxide for SC0034 R patient). Red color indicates more resistance and yellow color more sensitivity. IC₅₀ : inhibitory concentration 50.